These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4965505)

  • 1. Weight reduction with phenmetrazine and chlorphentermine a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):563-9. PubMed ID: 4965505
    [No Abstract]   [Full Text] [Related]  

  • 2. Weight reduction with chlorphenetermine and phenmetrazine in obese psychiatric patients during chlorpromazine therapy.
    Sletten IW; Ognjanov V; Menendez S; Sundland D; el-Toumi A
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):570-5. PubMed ID: 4965506
    [No Abstract]   [Full Text] [Related]  

  • 3. Chlorphentermine and phenmetrazine compared: weight reduction, side effects and psychological change.
    Sletten IW; Sundland D; Pichardo J; Viamontes G
    Mo Med; 1967 Nov; 64(11):927-9. PubMed ID: 6056101
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the usefulness of various preparations inhibiting hunger sensation].
    Krotkiewski M; Bielecka J; Ruzyllo E
    Pol Tyg Lek; 1968 Sep; 23(34):1277-80. PubMed ID: 5722527
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Cafilon in the treatment of obesity (author's transl)].
    Honzák R; Rath R; Vondra K
    Cesk Gastroenterol Vyz; 1976 Apr; 30(3):155-61. PubMed ID: 1277334
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic effect of various appetite depressants under controlled conditions].
    Kreze A; Toman A
    Bratisl Lek Listy; 1973; 59(4):406-12. PubMed ID: 4751882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Controlled clinical trials of a new appetite-inhibiting drug].
    Bani G; Barba C; Ricci G
    Clin Ter; 1968 Oct; 47(2):161-74. PubMed ID: 5702726
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenmetrazine vs. phenmetrazine with amobarbital for weight reduction: a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):750-4. PubMed ID: 4984039
    [No Abstract]   [Full Text] [Related]  

  • 9. Weight reduction with phenmetrazine: a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1967 Sep; 9(9):462-7. PubMed ID: 4963979
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chlorphentermine in the treatment of obesity].
    Chjnowski JR; Adamska-Dyniewska H; Leszczyński B; Mockallo T
    Pol Tyg Lek; 1968 Sep; 23(40):1531-3. PubMed ID: 5725611
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of anorexiants on plasma lipids and other physiological parameters in man.
    Gaut ZN; Pocelinko R; Abrams WB; Dalton C
    J Clin Pharmacol J New Drugs; 1969; 9(5):315-20. PubMed ID: 4899112
    [No Abstract]   [Full Text] [Related]  

  • 12. Weight control in obese diabetics. A comparative trial of Filon and phenmetrazine.
    Buckle RM; Silverstone JT
    Br J Clin Pract; 1966 Jul; 20(7):363-5. PubMed ID: 5940969
    [No Abstract]   [Full Text] [Related]  

  • 13. Anorexigenic drugs in perspective.
    Fineberg SK
    J Am Geriatr Soc; 1967 Jan; 15(1):51-8. PubMed ID: 6015545
    [No Abstract]   [Full Text] [Related]  

  • 14. [Patterns of glucose and pyruvate curves during treatment of obesity with chlorphentermine (Avipron)].
    Adamska-Dyniewska H; Kowalczyk L
    Wiad Lek; 1968 Nov; 21(21):1901-4. PubMed ID: 5714921
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience with a Hungarian-made chlorphentermine-type anorexigenig preparation (Desopimon) in the treatment of hypothalamopathies].
    Takács L; Pethö B
    Orv Hetil; 1969 Mar; 110(10):540-2. PubMed ID: 5779971
    [No Abstract]   [Full Text] [Related]  

  • 16. [Regulation of appetite in obese subjects by means of neutrotropic drugs].
    Gamski M; Komarnicka R
    Pol Tyg Lek; 1968 Oct; 23(44):1688-90. PubMed ID: 5701464
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the action of concentrated lucofen with prolonged effect].
    Godefroy G; Napolier A; Andriambao-Damasy S
    Mars Med; 1968; 105(3):289-93. PubMed ID: 5739899
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-lipaemic effect of Desopimon in obesity and in diabetes mellitus accompanied by obesity.
    Less E
    Ther Hung; 1974; 22(1):27-31. PubMed ID: 4844928
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary clinical evaluation of a new appetite suppressant. A double-blind study.
    Feldman HS
    J Med Soc N J; 1966 Oct; 63(10):454-7. PubMed ID: 5341753
    [No Abstract]   [Full Text] [Related]  

  • 20. Desopimon in the management of obesity associated with heart disease.
    Gonda F; Kenedi I
    Ther Hung; 1973; 21(2):82-4. PubMed ID: 4792883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.